Axa’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,223
| Closed | -$226K | – | 1107 |
|
|
2024
Q1 | $226K | Buy |
+8,223
| New | +$226K | ﹤0.01% | 1014 |
|
|
2022
Q4 | – | Sell |
-38,287
| Closed | -$2.14M | – | 1197 |
|
|
2022
Q3 | $2.14M | Buy |
38,287
+164
| +0.4% | +$9.18K | 0.01% | 749 |
|
|
2022
Q2 | $1.97M | Sell |
38,123
-741
| -2% | -$38.4K | 0.01% | 778 |
|
|
2022
Q1 | $2.82M | Hold |
38,864
| – | – | 0.01% | 772 |
|
|
2021
Q4 | $4.6M | Buy |
38,864
+463
| +1% | +$54.7K | 0.01% | 683 |
|
|
2021
Q3 | $5.15M | Buy |
38,401
+1,415
| +4% | +$190K | 0.01% | 671 |
|
|
2021
Q2 | $5.99M | Buy |
+36,986
| New | +$5.99M | 0.02% | 658 |
|